Publications by authors named "Tuende Borbath"

Claim this Profile
L
Linking Structure to Electrocatalytic Performance: Graphene Nanoplatelets-Derived Novel Mixed Oxide-Carbon Composites as Supports for Pt Electrocatalysts with Enhanced Stability.
Ilgar Ayyubov, Emília Tálas, Irina Borbáth, Zoltán Pászti, László Trif

Nanomaterials (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1.
Jean-Luc Van Laethem, Karen Geboes, Ivan Borbath, Teresa Macarulla Mercade, Aurélien Lambert

Cell Rep Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint-induced arthritis: a comprehensive single-cohort descriptive analysis from clinical evaluation to histology.
Laurent Meric de Bellefon, Francesco Natalucci, Adrien Nzeusseu Toukap, Tatiana Sokolova, Christine Galant, Ivan Borbath

Front Med (Lausanne)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downstaging and R0 resection of initially unresectable metastatic well-differentiated grade-3 pancreatic neuroendocrine tumor: a case report.
Arthur Houbiers, Joseph Weerts, Ghislain Houbiers, Roland Materne, Nancy Witvrouw, Ivan Borbath

Acta Chir Belg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to letter comments on: Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine).
D Malka, I Borbath, A Lopes, T Vandamme, J Edeline

ESMO Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatostatin analogue continuation upon progression in patients with gastroenteropancreatic neuroendocrine tumour (SAUNA trial): a randomised controlled trial protocol.
Siddharth Chhajlani, Jelka Kuiper, Philippe Beutels, Ivan Borbath, Wouter Dercksen

BMJ Open· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective internal radiation therapy for neuroendocrine liver metastases: efficacy, safety and prognostic factors. A retrospective single institution study.
D Briol, A Ceratti, R Lhommel, L Annet, C Dragean, I Borbath

Acta Gastroenterol Belg· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, phase III umbrella trial (SAFIR-ABC10-Precision Medicine).
D Malka, I Borbath, A Lopes, D Couch, M Jimenez

ESMO Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promoting large multinational academic clinical trials for gastrointestinal cancers in Europe: the ENGIC (European Network for GI Cancers) initiative.
J Taieb, J Seligmann, D Modest, C Girault, F Rivera, I Borbath

ESMO Open· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of γ-Irradiation Effects on EPDM/SBS Blends for Durability and Recycling Potential.
Traian Zaharescu, Marius Bumbac, Cristina Mihaela Nicolescu, Maria Daniela Stelescu, Tunde Borbath, Istvan Borbath

Polymers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of high-grade neuroendocrine neoplasms: impact of functional imaging.
O Islam, K Sarti, L Verbruggen, V Vandersmissen, K Vanden Bulcke, I Borbath

Endocr Relat Cancer· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Pt/TiSnO-C Composite Supported Electrocatalyst with Functionalized Carbon for Sustainable Energy Conversion Technologies.
Cristina Silva, Zoltán Pászti, Khirdakhanim Salmanzade, Dániel Olasz, Erzsébet Dodony

Nanomaterials (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroendocrine tumors in the stomach: An epidemiological analysis of Belgian Cancer Registry data 2010-2019.
Marlies Maly, Eduard Callebout, Suzane Ribeiro, Anne Hoorens, Saskia Carton, Ivan Borbath

J Neuroendocrinol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term clinical and radiological outcomes of endoscopic ultrasound-guided radiofrequency ablation of benign insulinomas.
Zoé Debraine, Ivan Borbath, Pierre Deprez, Florence Bosly, Dominique Maiter

Clin Endocrinol (Oxf)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemiluminescence-based evaluation of styrene block copolymers' recyclability.
Marius Bumbac, Traian Zaharescu, Cristina Mihaela Nicolescu, Tunde Borbath, Istvan Borbath

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study.
Jean-Charles Nault, Nanthara Sritharan, Gontran Verset, Ivan Borbath, Marie Lequoy

JHEP Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High magnetization composite magnetic fluid: structure, magnetorheology and new sealing mechanism in rotating seals.
Daniela Susan-Resiga, Vlad-Mircea Socoliuc, István Borbáth, Tünde Borbáth, Septimiu Casian Tripon

Soft Matter· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study.
Jean-Luc Van Laethem, Ivan Borbath, Hans Prenen, Karen Paula Geboes, Aurélien Lambert

Lancet Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Composites of Titanium-Molybdenum Mixed Oxides and Non-Traditional Carbon Materials: Innovative Supports for Platinum Electrocatalysts for Polymer Electrolyte Membrane Fuel Cells.
Ilgar Ayyubov, Emília Tálas, Irina Borbáth, Zoltán Pászti, Cristina Silva

Nanomaterials (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): final results of a randomised phase 3 study.
Thomas Yau, Ahmed Kaseb, Ann-Lii Cheng, Shukui Qin, Andrew X Zhu, Ivan Borbath

Lancet Gastroenterol Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors.
Debbie Robbrecht, Jean-Jacques Grob, Oliver Bechter, Matteo Simonelli, Bernard Doger, Ivan Borbath

Clin Transl Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Watch-an-wait strategy for multiple rectal neuroendocrine tumors with widespread invasion.
N Torres, M El Moussaoui, S Basbous, V Fridman, I Borbath

Acta Gastroenterol Belg· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability Qualification of Resins/Metallic Oxide Composites for Surface Oxidative Protection.
Traian Zaharescu, Radu Mirea, Tunde Borbath, Istvan Borbath

Polymers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial.
Christelle Bouchart, Julie Navez, Ivan Borbath, Karen Geboes, Timon Vandamme

BMC Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Contribution of BaTiO to the Stability Improvement of Ethylene-Propylene-Diene Rubber: Part II-Doped Filler.
Traian Zaharescu, Alina Dumitru, Tunde Borbath, Ioana Ionescu, Istvan Borbath

Polymers (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis